Conversely, a large number of our study participants were utilized with G-CSF 17 (11.6%) and oral ciprofloxacin 17 (11.6%) during the 3rd cycle chemotherapy to prevent infection associated with neutropenia. The gene discussed is CSF3; the disease is Decreased total neutrophil count.